Discussion “Comparsion of the Bieoquvalence of Generic Versus Branded Clozapine”
Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.
Dr. Meyer: How does the evidence presented today speak to the issues of bioavailability, bioequivalence, and interchangeability for clozapine? Are we convinced that there is no problem whatsoever with the 100-mg tablet of the generic product?
Dr. Lam: I think the reverse is true.
Dr. Glazer: The signal that is emerging from the available studies gives us reason for concern.
J Clin Psychiatry 2001;62(suppl 5):23-24Related Articles